Trial · NCT01522976
Adverse events645
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 645
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Arm 1: Azacitidine/Lenalidomide | 76 | 89 | |
| other | Anemia | Blood and lymphatic system disorders | Arm 2: Azacitidine | 71 | 91 | |
| other | Anemia | Blood and lymphatic system disorders | Arm 3: Azacitidine/Vorinostat | 72 | 91 | |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm 1: Azacitidine/Lenalidomide | 13 | 89 | |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm 2: Azacitidine | 14 | 91 | |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm 3: Azacitidine/Vorinostat | 13 | 91 | |
| other | Chest pain - cardiac | Cardiac disorders | Arm 1: Azacitidine/Lenalidomide | 3 | 89 | |
| other | Chest pain - cardiac | Cardiac disorders | Arm 2: Azacitidine | 2 | 91 | |
| other | Chest pain - cardiac | Cardiac disorders | Arm 3: Azacitidine/Vorinostat | 6 | 91 | |
| other | Sinus tachycardia | Cardiac disorders | Arm 1: Azacitidine/Lenalidomide | 3 | 89 | |
| other | Sinus tachycardia | Cardiac disorders | Arm 2: Azacitidine | 4 | 91 | |
| other | Sinus tachycardia | Cardiac disorders | Arm 3: Azacitidine/Vorinostat | 9 | 91 | |
| other | Abdominal pain | Gastrointestinal disorders | Arm 1: Azacitidine/Lenalidomide | 8 | 89 | |
| other | Abdominal pain | Gastrointestinal disorders | Arm 2: Azacitidine | 14 | 91 | |
| other | Abdominal pain | Gastrointestinal disorders | Arm 3: Azacitidine/Vorinostat | 21 | 91 | |
| other | Constipation | Gastrointestinal disorders | Arm 1: Azacitidine/Lenalidomide | 49 | 89 | |
| other | Constipation | Gastrointestinal disorders | Arm 2: Azacitidine | 54 | 91 | |
| other | Constipation | Gastrointestinal disorders | Arm 3: Azacitidine/Vorinostat | 44 | 91 | |
| other | Diarrhea | Gastrointestinal disorders | Arm 1: Azacitidine/Lenalidomide | 42 | 89 | |
| other | Diarrhea | Gastrointestinal disorders | Arm 2: Azacitidine | 23 | 91 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01522976/events